Cite
MLA Citation
D. Dutzer et al.. “Letter: new thresholds need to be defined when using point of care assays to monitor infliximab trough levels in IBD patients.” Alimentary pharmacology & therapeutics, vol. 47, no. 11, 2018, pp. 1571–1573. http://access.bl.uk/ark:/81055/vdc_100085010464.0x00003d